Grail News

Aktie
WKN:  A40F8M ISIN:  US3847471014 US-Symbol:  GRAL Land:  USA
44,14 €
-0,86 €
-1,91%
10:32:07 Uhr
Depot/Watchlist
Marktkapitalisierung *
2,80 Mrd. €
Streubesitz
24,25%
KGV
-9,73
Index-Zuordnung
-

Grail News

22.04.26 - PR Newswire
GRAIL to Announce First Quarter 2026 Financial Results
GRAIL to Announce First Quarter 2026 Financial Results PR Newswire
21.04.26 - PR Newswire
GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at 2026 ASCO Annual Meeting
GRAIL to Present New Data From NHS-​Galleri and PATHFINDER 2 at 2026 ASCO Annual Meeting PR Newswire
15.04.26 - PR Newswire
GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES
GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES PR Newswire
07.04.26 - PR Newswire
GRAIL Announces Integration of the Galleri® Test into Epic Electronic Health Record Platform to Expand Access Nationwide
GRAIL Announces Integration of the Galleri® Test into Epic Electronic Health Record Platform to Expand Access Nationwide PR Newswire
01.04.26 - PR Newswire
Cancer Is Striking Earlier -- Superpower and GRAIL Are Partnering to Expand Early Detection
Cancer Is Striking Earlier -- Superpower and GRAIL Are Partnering to Expand Early Detection PR Newswire
01.04.26 - PR Newswire
GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES
GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES PR Newswire
25.03.26 - PR Newswire
GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES
GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES PR Newswire
18.03.26 - PR Newswire
LEVI & KORSINSKY, LLP: GRAIL (GRAL) GUIDED TO 2030 CASH RUNWAY WHILE KEY TRIAL RISK WENT UNADDRESSED
LEVI & KORSINSKY, LLP: GRAIL (GRAL) GUIDED TO 2030 CASH RUNWAY WHILE KEY TRIAL RISK WENT UNADDRESSED PR Newswire
12.03.26 - PR Newswire
GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor
GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor PR Newswire
04.03.26 - PR Newswire
GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES
GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES PR Newswire
02.03.26 - PR Newswire
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
24.02.26 - PR Newswire
GRAIL to Present at the TD Cowen 46th Annual Health Care Conference
GRAIL to Present at the TD Cowen 46th Annual Health Care Conference PR Newswire
24.02.26 - PR Newswire
GRAL INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Launches Investigation into GRAIL, Inc., Encourages Investors and Potential Witnesses to Contact Law Firm
GRAL INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Launches Investigation into GRAIL, Inc., Encourages Investors and Potential Witnesses to Contact Law Firm ...
19.02.26 - PR Newswire
GRAIL Reports Fourth Quarter and Full Year 2025 Financial Results
GRAIL Reports Fourth Quarter and Full Year 2025 Financial Results PR Newswire
19.02.26 - PR Newswire
Landmark NHS-Galleri Trial Demonstrates a Substantial Reduction in Stage IV Cancer Diagnoses, Increased Stage I and II Detection of Deadly Cancers, and Four-Fold Higher Cancer Detection Rate
Landmark NHS-​Galleri Trial Demonstrates a Substantial Reduction in Stage IV Cancer Diagnoses, Increased Stage I and II Detection of Deadly Cancers, and Four-Fold Higher ...
16.02.26 - PR Newswire
GRAIL to Announce Fourth Quarter and Full Year 2025 Financial Results
GRAIL to Announce Fourth Quarter and Full Year 2025 Financial Results PR Newswire
29.01.26 - PR Newswire
GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test
GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-​Cancer Early Detection Test PR Newswire
15.12.25 - PR Newswire
GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference
GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference PR Newswire
01.12.25 - PR Newswire
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
18.11.25 - PR Newswire
GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference
GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference PR Newswire

Newssuche

Videos

newspaper
20.04.26 -1,81%
Technical Trading: GBP Long im Trend
GBP/USD Long Typ: Open End Turbo WKN: VV7A4S Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »